Please use this identifier to cite or link to this item:
Title: Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma.
Authors: Shikotra, A.
Choy, D. F.
Ohri, C. M.
Doran, E.
Butler, C.
Hargadon, B.
Shelley, M.
Abbas, A. R.
Austin, C. D.
Jackman, J.
Wu, L. C.
Heaney, L. G.
Arron, J. R.
Bradding, P.
First Published: Jan-2012
Citation: Journal of Allergy and Clinical Immunology, 2012, 129 (1), pp. 104-11.e1-9-104-11.e1-9
Abstract: Thymic stromal lymphopoietin (TSLP) is a cytokine implicated in the pathophysiology of asthma through 2 distinct pathways: a TSLP-OX40 ligand (OX40L)-T cell axis and a TSLP-mast cell axis. Whether these pathways are active in human asthma is unknown.
DOI Link: 10.1016/j.jaci.2011.08.031
eISSN: 1097-6825
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.